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Abstract
Activation-induced cytidine deaminase (AID), produced by the Aicda gene, is essential for the immunoglobulin gene (Ig)
alterations that form immune memory. Using a Cre-mediated genetic system, we unexpectedly found CD4
+ T cells that had
expressed Aicda (exAID cells) as well as B cells. ExAID cells increased with age, reaching up to 25% of the CD4
+ and B220
+
cell populations. ExAID B cells remained IgM
+, suggesting that class-switched memory B cells do not accumulate in the
spleen. In T cells, AID was expressed in a subset that produced IFN-c and IL-10 but little IL-4 or IL-17, and showed no
evidence of genetic mutation. Interestingly, the endogenous Aicda expression in T cells was enhanced in the absence of B
cells, indicating that the process is independent from the germinal center reaction. These results suggest that in addition to
its roles in B cells, AID may have previously unappreciated roles in T-cell function or tumorigenesis.
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Introduction
Activation-induced cytidine deaminase (AID) is essential for
somatic hypermutation (SHM) and class switch recombination
(CSR), which diversify the immunoglobulin gene in activated
peripheral B cells [1,2]. SHM introduces point mutations in the V
region exon, thus contributing to the antibody affinity maturation
associated with cell selection. CSR is a region-specific DNA
recombination that occurs between two switch regions located 59
to each heavy chain constant (CH) region gene. This recombina-
tion replaces the VH-proximal CH gene with a downstream CH
gene by looping out the intervening sequence, thereby generating
isotype-switched antibodies without changing the antigen speci-
ficity [3].
Both CSR and SHM are initiated by AID that induces the
target DNA cleavages [4,5]. In addition to immunoglobulin (Ig)
genes, a considerable number of non-Ig genes, including proto-
oncogenes, can be attacked by AID [6]. Furthermore, a growing
number of reports suggest that, because of its mutagenic activity,
AID may be involved in tumorigenesis in both B and non-B cells
[7–12]. Studies indicate that the incidence of lymphoma carrying a
Myc-Ig translocation is drastically reduced in AID-deficient mice
[7,12]. In contrast, systemic AID overexpression in transgenic
mice consistently results in T-cell lymphoma, as well as lung
tumor, liver tumor, and B lymphoma, with lower frequencies [13–
16]. Notably, tumorigenic hepatitis C virus or H. pylori infection
can induce AID expression [10,17]. AID thus appears to be
genotoxic, and its expression must be tightly regulated.
We previously showed in vitro that Aicda expression is regulated
by a balance between enhancers and silencers [18]. The silencers
E2f and c-Myb strongly repress Aicda transcription in non-B cells
and non-stimulated B cells. When B cells are stimulated, B-cell-
specific (Pax5 and E2a) and stimulation-responsive (NF-kB,
STAT6, Smd3/4, and C/EBP) enhancers act in concert to
overcome the silencers, thereby turning on Aicda transcription
[18]. This model explains the mechanism by which AID is
restricted primarily to activated B cells, yet can be induced in non-
B cells by strong environmental stimuli [18].
In fact, high AID levels are found only in germinal-center (GC)
B cells, which actively undergo SHM and CSR [19]. Small
amounts of AID have been found in immature B cells, although
the amount of AID and the percentage of AID-positive immature
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SHM and CSR have been observed in these cells, suggesting that
AID might be involved in antigen-independent immunoglobulin
diversification in B cells at an early developmental stage [20–22].
In addition, involvement of AID in B cell central tolerance in both
human and mouse was suggested by recent two publications
[23,24]. These observations imply that even subtle level of AID
expression would have important role in regulation of immune
system. Small amounts of AID have also been found in the mouse
ovary and human testis [25,26], although AID’s function in germ
cells is not well established, since AID-deficient mice reproduce
without obvious genetic disorders.
AID is difficult to detect convincingly at low levels. To
overcome this problem, we introduced a genetic marking system
using bacteria artificial chromosome (BAC) transgenic mice
carrying Cre-ires-hCD2 knocked into the Aicda locus [27]. We
also crossed this mouse with a genetically marked reporter mouse.
This system allowed us to examine both past and current AID
expression by detecting two genetic markers. Since the marked
cells can accumulate in a cell population, the detection sensitivity
for AID-expression history can be enormously enhanced. Using
this system, we unexpectedly found that AID is expressed in a
considerable fraction of CD4
+ memory T cells in mice maintained
under specific pathogen-free conditions.
Results
The Aicda-cre system efficiently monitors Aicda
expression
The Aicda-cre transgenic mouse carries a 190-kb BAC DNA
containing the entire Aicda locus (Figure S1A) [27]. The Aicda
coding region on the transgene was engineered to generate the
human CD2 and Cre recombinase instead of AID; thus, current
Aicda promoter activation can be visualized by hCD2 staining. In
addition, by crossing these mice with Rosa26 reporter mice (R26R
or Rosa-tdRFP), previous Aicda promoter activation can be
visualized, because Cre irreversibly turns on LacZ or RFP
reporter expression at the Rosa26 locus (Rosa reporters) [28,29].
We analyzed the Aicda-cre/R26R and Aicda-cre/Rosa-tdRFP
mice and found substantial numbers of LacZ/RFP single-positive
(exAID) and LacZ/RFP hCD2 double-positive B cells in
secondary lymphoid organs (Figure 1A and Figure S1B). The
majority of LacZ
+hCD2
+ B cells were peanut-agglutinin (PNA)
positive, either CD38
2 or CD95
+, marking them as GC B cells
(Figure 1A and Figure S1B); Rosa single-positives contained only a
small fraction of GC B cells. This indicates that cells quickly lost
AID expression after leaving the GC. Nonetheless, IgA
+
plasmablasts, which should have expressed AID, were almost
completely labeled by RFP in the Aicda-cre/Rosa-tdRFP mice
(Figure 1B and 1C).
Initially, we thought the exAID B cells were post-GC cells.
However, these cells comprised a substantial fraction of the B220
+
cells in the spleen of young animals (3–4 weeks), although the
percentage varied from 3–23% for unknown reasons (Figure 1D).
The percentage of exAID B cells remained fairly stable at 5–10%
between 5–40 weeks of age, after which it gradually increased,
reaching a plateau of 20–25% (Figure 1D). The absolute numbers
of exAID B cells followed a similar tendency; this was less
apparent, however, perhaps due to the inevitable technical
fluctuations of cell yield in each experiment (Figure S1C). The
majority of accumulated exAID B cells in old animals remained
IgM
+IgD
+, but SHM on the IgV downstream region was
significant (Figure S1D and Table 1), suggesting that switched
memory B cells may not accumulate in the spleen.
To determine if exAID cells could appear in a pre-GC
population, we analyzed each stage of B-cell development. We
found a few exAID cells among the immature B cells in bone
marrow (Figure 2A and 2B). The fraction of exAID cells increased
in the immature B cells in the periphery; transitional (T) 2 B cells
included more than 7% exAID cells. We could not observe the
hCD2 expression in immature cells by conventional hCD2
staining method, but the expression was confirmed by RT-PCR
(Figure 2C) [21,22,30]. These results suggest that the exAID B-cell
population found in the spleen may be, at least in part, generated
in pre-GC stages. Taken together, the current Aicda-cre/Rosa-
reporter system appeared to be sensitive to a much lower level of
Aicda expression than could be detected by staining.
ExAID cells in CD4
+ T cells
Surprisingly, exAID cells also comprised about 7% of the
CD3
+CD4
+ T cells in the spleen of 7-month-old Aicda-cre/R26R
mice (Figure 3A and Figure S2AB). The frequency of exAID
CD3
+ CD8
+ T cells was much lower than in CD3
+CD4
+ T cells.
No clear hCD2
+ T cells were observed, indicating that the Aicda
expression in T cells is either very weak or rare at any given
moment. ExAID CD4
+ T cells had the effector memory (EM)
phenotype (CD44
+ CD62L
lo) in the spleen [31,32], lymph nodes
and Peyer’s patches, and few, if any, LacZ
+ naı ¨ve T cells were
observed (Figure 3C and Figure S2C). A small fraction of NK cells
also expressed the Rosa marker (Figure S3A). In the thymus,
exAID cells were not found in either CD4/CD8 double-positive or
single-positive fractions (Figure 3B). Taken together, exAID T cells
are likely to be generated in association with T-cell activation in
the periphery. The percentage of LacZ
+CD4
+ T cells was
consistently negligible in mice younger than 20 weeks, but
gradually increased to around 25% of the total CD4
+ T cells at
around 18 months, although there were variations in individual
animals (Figure 3D and Figure S3B). Furthermore, by crossing
Aicda-cre/Rosa-tdRFP mice with Fucci transgenic mice, in which
a cell-cycle indicator produces an Azami Green signal in the S/
G2/M phase [33], we found that exAID CD4
+ EM T cells
proliferated as steadily as non-exAID EM T cells (Figure 3E). In
the CD8
+ (or CD4
2) fraction there were generally very few exAID
cells, which did not increase as quickly as those in CD4
+ cells
except in a couple of older animals (Figure S3C). It is thus likely
that a certain fraction of activated CD4
+ T cells, and a smaller but
still detectable fraction of CD8
+ T cells, can induce Aicda
expression, and such exAID T cells can accumulate with age.
AID expression in GC B cells is associated with the
environment, in which T-B interaction plays a critical role. To
examine the possibility that the Aicda expression in T cells depends
on B cells, we crossed the Aicda-cre/R26R mouse with the mMT
mouse, which has virtually no B cells (Figure 4A) [34,35]. As
shown in Figure 4B, there was no difference in the percentage of
exAID cells found among the EM T cells in the mMT versus wild-
type (WT) background. We conclude that T-B interaction is not
essential for exAID T-cell generation, and that exAID T cells can
develop without the GC reaction.
Endogenous AID mRNA expression in T cells
To examine whether the endogenous Aicda gene is expressed in
T cells, we performed RT-PCR on LacZ
+ and LacZ
2 EM T cells,
as well as naive T cells, sorted from pooled spleen and lymph node
cells. A TaqMan probe that detects the exon 1–2 region of AID
mRNA was used, because it does not detect the Aicda-cre
transgene product. We detected weak but clear signals from the
LacZ
+ CD4
+ T cells (Figure 4C). The signal strength was one-
tenth of that from immature B cells, and similar to that of mature
Aicda Expression in T Cells
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each sample, B-cell contamination was unlikely. Furthermore, we
did the same experiment with Aicda-cre/R26R/mMT mice, and
detected substantial AID mRNA levels in the LacZ
+ T cells. These
levels were higher than in WT LacZ
+ T cells, and as high as in
immature B cells (Figure 4C). In accordance with the PCR results,
the hCD2 levels were much higher in the lymph node T cells of
Aicda-cre/R26R/mMT mice than in those of WT mice
(Figure 4D). We conclude that LacZ
+ CD4
+ T cells indeed
expressed endogenous AID mRNA.
Properties of exAID T cells
In T cells, Aicda expression occurred primarily in the activated
CD4
+ fraction. To examine whether there are functional
differences between exAID and non-exAID cells, we first analyzed
the localization of exAID T cells within lymphoid organs. Sections
of a Peyer’s patch from an Aicda-cre/Rosa-tdRFP mouse were
stained with antibodies for CD3 and AID. A cluster of RFP
+AID
+
cells, which indicated GCs, included dispersed CD3
+ cells
(Figure 5). Scattered RFP
+AID
+ B cells could be seen at the edge
of the T-B zone, which was consistent with our previous report
(Figure 5) [36]. CD3
+RFP
+ T cells were seen throughout the area,
including the GC, T zone, and T-B border (Figure 5). These
results suggest that the exAID T cells may not have a special
localization within lymphoid tissue.
Consistent with the histological observations, there was no
difference in the expression of CXCR4 and CXCR5, which
determine cellular localization in the lymphoid organ, between
exAID and non-exAID EM CD4
+ T cells (Figure 6A). However,
we observed small but recognizable differences in the CCR7 and
PSGL-1 levels (Figure 6A), suggesting that the exAID cells might
have acquired some type of functional difference. On the other
hand, there was no difference in ICOS, an important co-
stimulatory molecule for T-B interaction (Figure 6A).
Older animals bear a unique T-cell subset with diminished
reactivity, namely PD-1
+ memory phenotype CD4
+ T cells [37].
Because the fraction of exAID T cells increased with age, we
checked for PD-1 in LacZ
+ T cells from the spleen of aged Aicda-
cre/R26R mice. The majority of CD62L
loLacZ
+CD4
+ T cells
expressed PD-1, while PD-1 was barely detectable in the CD62L
hi
naı ¨ve T cells (Figure S3D). The CD62L
lo LacZ
2 CD4
+ T cells
were a mixture of PD-1-positive and -negative cells (Figure S3D).
Therefore, the exAID T cells found in aged mice seem to be
included in a population of PD-1
+ memory CD4
+ T cells that has
been previously reported [37].
CD4
+ T cells can be classified into several subsets, such as Th1,
Th2, and Th17, according to their cytokine profiles [38–40]. Each
subset can be induced by different sets of stimuli [39,40]. If the
Aicda expression in CD4
+ T cells is associated with specific
activating conditions, the cytokine profile of the exAID subset
could be biased. To examine the cytokine signature, we purified
LacZ
+ EM CD4
+ T cells and other control cells, and then
stimulated them by phorbol myristate acetate (PMA) and
ionomycin. Naive cells secreted interleukin (IL)-2 and TNF-a,
but no other cytokines typical to Th1, Th2, or Th17 (Figure 6B).
The LacZ
2 EM T cells secreted all of the cytokines examined,
indicating that, as expected, this population contained various
types of Th-cell subsets. By contrast, the exAID T cells produced
lower levels of IL-2 and negligible amounts of IL-4, IL-17, and
TGF-b. However, the IL-10 and interferon-c productions were
comparable to those of LacZ
2 EM T cells (Figure 6B and 6C).
The exAID T cells also produced TNF-a at a level similar to the
naive T cells. Stimulation with anti-CD3 plus anti-CD28 gave
essentially the same results (Figure S4A). The bias in the cytokine
signature suggests that Aicda expression may be associated with
specific signals.
To examine whether in vitro stimulation can induce Aicda
expression in T cells, we cultured naive CD4
+ T cells with
combinations of various cytokines that can induce either Th1,
Th2, or Th17 cells in vitro. However, none of these culture
conditions induced LacZ
+ T cells (Figure S4B). Given the slow
accumulation of LacZ
+ T cells in vivo (Figure 3D), the frequency of
Aicda expression in T cells should be so low that it would not be
detectable in short-term culture. Alternatively, Aicda expression
might require a unique in vivo environment that is absent in the
culture system.
In contrast, adoptive in vivo transfer of naı ¨ve CD4
+ T cells or
Aicda-cre/RFP
2 EMCD4
+T cellsintoT cell-deficient(CD3e
2/2)
mice revealed that a considerable fraction of cells expressed
Aicda and become RFP
+ cells (Figure 7A). The frequency of
RFP
+ T cells generated from the RFP
2 EM T cells was much
Table 1. Mutation frequency of Jh4 downstream intron of Igh of B220
+ CD3
2 cells.
Cell Mutation rate(/base pair) Mutated base/Total base Mutated clone/Total clone
LacZ
2 hCD2
2 1.0610
25 1/96,000
a,b 1/160
LacZ
+ hCD2
2 3.0610
24 30/98,400
a 10/164
LacZ
+ hCD2
+ 8.3610
24 75/90,600
b 8/151
P value (two tail Fisher’s exact test):
a,p=3 . 2 610
28;
b,p=2 . 3 610
222.
Statistical comparisons between two types of cells (a- and b-pairs) were done by use of 262 contingency tables made by Mutated base/Total base of each pair.
doi:10.1371/journal.pone.0029141.t001
Figure 1. Aicda-cre/R26R or /Rosa-tdRFP B cells are efficiently marked upon their activation in vivo. (A) Peripheral lymphoid organs of
Aicda-cre/R26R 21-week-old mice were stained with B220, human CD2, PNA, and CD38. Histograms show CD38 and PNA expressed in LacZ
+ hCD2
+
and LacZ
+ hCD2
2 cells. SPL, spleen; mLN, mesenteric lymph node; PP, Peyer’s patch. (B) Immunofluorescence analysis of the small intestine of an
Aicda-cre/Rosa-tdRFP mouse. IgA (green), RFP (red), and DAPI (blue) signals are shown together. The right panel shows an enlarged view of the area
outlined in the left panel. Bar represents 100 mm. (C) FACS analysis of lamina propria cells from the small intestine of an Aicda-cre/Rosa-tdRFP mouse.
(D) The percentage of B cells with the Rosa
+ (LacZ or RFP) hCD2
2 among B220
+ cells in the spleen, plotted by age (in weeks); symbols indicate
individual mice. Correlation coefficient (r) was 0.65. Human CD2 and LacZ expression in B220
+ spleen cells from a 4-week-old Aicda-cre/R26R mouse
are shown (rightmost panel).
doi:10.1371/journal.pone.0029141.g001
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RFP
+ cells generated from RFP
2 EM T cells appeared to be
located predominantly in the mesenteric lymph nodes (mLN)
and small intestine (Si) lamina propria while majority remained
RFP
2 in the spleen, suggesting that RFP
+ EM T cells might be
generated upon activation of EM T cells by environmental
stimuli in the gut (Figure 7A). Both RFP
+ and RFP
2 EM
phenotype T cells did not expand in CD3e
2/2 mice as
compared with naı ¨ve T cells (Figure 7B). We did not find any
difference in the recovered-cell number between the transfer of
RFP
+- and RFP
2-cells. It suggested that RFP
+- and RFP
2-cells
have similar capability for proliferation even after the transfer;
the result is consistent with the result obtained by cell cycle
indicator mice (Figure 7B and Figure 3E). We next explored the
cytokine signature of transferred T cells recovered from CD3e
2/
2 mice. A similar fraction of RFP
+ and RFP
2 EM cells became
IFN-c/IL-10 double-producing cells, consistent with their initial
cytokine profile before transfer (Figure 7C and Figure 6B).
Taken together, Aicda expression in T cells seems to be induced
under specific in vivo conditions in response to stimuli derived
from gut environment, with the resultant exAID T cells
acquiring distinct functional properties, at least in the cytokine
profile.
It is important to know whether the AID in T cells plays any
role in T-cell functions. Aberrant AID expression could cause
mutations in proto-oncogenes, such as Myc [6,8,14]). However, we
could not find AID-dependent mutations in exAID T cells at the
Myc mutation hotspot through sequencing (Table 2 and S1). T cell
antigen receptor (TCR) genes are other possible SHM targets [14].
We sorted the hCD2
+ LacZ
+ T cells from mMT background mice,
and a mixture of TCR cDNAs were randomly cloned for
sequencing analysis; however, no significant difference in mutation
frequency was observed between the LacZ
+hCD2
+ and
LacZ
2hCD2
2 fractions (Table S2). Nevertheless, we cannot
Figure 2. Low-level Aicda expression visualized in immature B cells. (A) Bone marrow (BM) cells of 7-week-old Aicda-cre/R26R mice were
stained by the indicated markers. The corresponding gate for each panel is indicated. Numbers in each quadrant indicate the percentage of gated
cells. (B) Aicda-cre/R26R spleen (SPL) cells were stained for the indicated markers. Gated areas are indicated in the top panels. (A)(B) Mean values and
standard deviations of the percentage of LacZ+ cells in three 7,8-week old mice were as following: preB=0.3360.16, imB=1.0360.23,
T1=4.9661.35, T2=7.7462.99, mB=7.9662.69, MZB=6.5462.97. (C) Aicda expression is shown for each B-cell stage detected by RT-PCR; values
were normalized to the Gapdh expression. Expression levels are presented relative to the average signal of germinal center B cells. The data represent
the average of three independent experiments with standard deviation. R1, region 1; R2, region 2; preB, premature B cell; imB, immature B cell; T1,
transitional B cell 1; T2, transitional B cell 2; mB, mature B cell; MZB, marginal zone B cell; GCB, germinal center B cell.
doi:10.1371/journal.pone.0029141.g002
Aicda Expression in T Cells
PLoS ONE | www.plosone.org 5 December 2011 | Volume 6 | Issue 12 | e29141Figure 3. Aicda-cre/R26R mice reveal the history of Aicda expression in a subset of T cells. Spleen T cells (A), thymocytes (B), and
peripheral lymphoid organs (C) from Aicda-cre/R26R mice were stained with the markers indicated. The gating used for each plot is shown at the top
of each panel. Data shown is for 29-week-old (A and C) or 7-week-old (B) animals. Numbers in the panels show the percentage of gated cells of each
Aicda Expression in T Cells
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accumulated mutations, because the TCR sequencing analysis
showed only the average in the total population analyzed.
AID expression in other tissues
AID expression in non-lymphocytes has been observed with
viral or bacterial infection, or under other inflammatory conditions
[10,17]. AID has also been found in non-lymphoid tissues, mouse
ovary [25], and human testis [26] under normal conditions. We
therefore histologically examined non-lymphoid tissues, including
the testis and ovary of Aicda-cre/Rosa-tdRFP mice, and found
RFP-positive cells in both the seminiferous tube and the ovary
(Figure S5AB). However, only one or two tubes per tissue section
contained RFP
+, suggesting that Aicda is occasionally expressed in
a few spermatocytes in normal spermatogenesis. In the ovary,
many granulosa cells and Theca externa cells were RFP-positive.
We could not find RFP
+ oocytes so far as we examined. We also
could not find clear RFP signals in any other tissues examined so
far, which include the pancreas, cerebellum, cerebrum, lung, liver,
and kidney (unpublished observations).
Discussion
In the present study, we employed a highly sensitive monitoring
system for in vivo Aicda promoter activation and found a new
fraction of CD4
+ T cells that expressed Aicda at some point. This
observation convincingly demonstrates that AID can be expressed
in non-B somatic cells under physiological conditions. Such T-cell
populations may not be discovered by conventional procedures,
because less than 1% of the CD4
+ T cells expressed hCD2 or AID
at any given time point. Despite this low frequency, exAID CD4
+
T cells accumulated with age, eventually making up about 25% of
the CD4
+ T-cell population. This raises the possibility that these
cells play distinctive functions in long-term phenomena such as
immune-memory or immunosenescence, rather than in short-term
responses.
Kwon et al. (2008) demonstrated that the efficiency of Cre-
mediated deletion induced by the Aicda-cre transgene varies
between the different floxed reporters present in the Tcfe2a
floxed and
R26R
eyfp alleles. Only 20% of the GC B cells recombine R26R
eyfp,
whereas almost all of the GC B cells recombine Tcfe2a
floxed,
suggesting that Cre’s accessibility to a given locus is an important
factor for conditional mutagenesis. Although the two reporter
genes used in this study were inserted into the Rosa26 locus, which
is similar to the R26R
eyfp allele, both of them allowed us to detect
Cre activity with apparently higher sensitivity than that obtained
with the R26R
eyfp. Therefore, the sensitivity of the Rosa26 system
also seems to depend on the structure of the integrated reporter
gene itself. Furthermore, despite its high efficiency in GC B cells,
the Tcfe2a
floxed allele fails to reveal Aicda-cre activity in immature B
and T cells [27], suggesting that Cre’s accessibility to a given target
gene may also vary in different cell types and developmental
stages. These results imply that the fluctuating factors discussed
above strongly influence the outcome of Cre-mediated conditional
mutagenesis. Importantly, however, the Cre-positive cells detected
with the more sensitive reporter system used in this study could not
have been false positives, because they both depended on Aicda-
cre and expressed Aicda transcripts, as shown by RT-PCR.
The exAID T cells expressed IFN-c and IL-10, but little IL-4 or
IL-17, indicating that they do not match any typical CD4
+ T-cell
subset. Actually, substantial fraction of cells expressed both IFN-c
and IL-10 as obvious in the intracellular staining. The IFN-c
production implies Th1, but IL-10, which has broad anti-
inflammatory activity, has not been considered a typical Th1
cytokine [41]. Recently, however, cells producing IL-10 have been
found in chronic infections caused by protozoa such as Toxoplasma
gondii and Leishmania major [42,43]. These IL-10-producing Th1
cells are the major source of IL-10 in mice suffering from chronic
intracellular parasite infection. IL-10 protects host animals from
mortal hyperinflammation by T. gondii, while it prevents the
healing of skin lesions in animals infected with L. major [42,43].
Although our mice were not infected with such protozoa,
environmental antigens might occasionally stimulate T cells,
thereby activating the regulatory cytokine program. Besides, the
exAID EM T cells express slightly higher CCR7 and lower PSGL-
1 in comparison with the non-exAID EM T cells. Because CCR7
and PSGL-1 is involved in leukocyte homing to lymphoid organ
and effector site, respectively, exAID T cells might have some
tendency closer to the central memory T cells although CD62L
expression were not high [32]. The fact that exAID T cells
acquired a cytokine signature and a homing receptor pattern
distinct from other T cells suggests that the Aicda expression in T
cells is associated with some specific stimuli.
A recent report demonstrated a unique PD-1
+ T-cell subpop-
ulation that is characteristic of aged animals [37]. These cells have
memory phenotypes but hardly proliferate in response to TCR
stimulation, and they produce fewer typical T-cell cytokines [37].
We found that most of the exAID CD4
+ T cells in the spleen of
aged animals were PD-1
+, but many PD-1
+ cells remained LacZ-
negative. Therefore, it is possible that a fraction of the PD-1
+
memory phenotype CD4
+ T cells might comprise of heteroge-
neous cells, some of which express Aicda sometime during their
development. Interestingly, C/EBPa, which has a binding motif
involved in Aicda expression [18], is highly expressed in the PD-1
+
T-cell population [37].
What kind of stimuli might be involved in Aicda expression in T
cells? Aicda expression was not induced in T cells in our in vitro
culture experiments with various polarizing conditions; thus the
conventional stimulation to activate T cells is not sufficient to
induce Aicda expression efficiently. In contrast, a considerable
fraction of effector memory cells as well as naı ¨ve CD4
+ T cells
became RFP
+ upon in vivo transfer into T cell-deficient mice,
suggesting that AID upregulation may take place during
homeostatic expansion, induced likely by antigens from the
commensal bacteria [44,45]. It has been reported that IL-10-
producing Th1 cells are generated by stimulation with a high
antigen dose in conjunction with IL-12 in vitro [46]. Therefore,
strong antigen stimulation might also be involved in generating
exAID T cells. TCR crosslinking induces NF-kB signaling [47,48],
which can also promote Aicda expression [18]. NF-kB can also be
activated through Toll-like receptors, which are important for
Aicda expression in immature B cells [20]. Th1 cells express TLR2
quadrant/gate. (A) R26R (Aicda-cre
2) is shown as a negative control. (C) R1 and R2 gating represents EM and naive T-cell populations, respectively.
FACS data shown in (B) are representative of analyses of the thymus in three independent experiments, using mice aged 7, 15, and 18 weeks. (D) The
percentage of LacZ
+ (diamond) or RFP
+ (cross) cells in CD4
+ T cells in the spleen, plotted by age. Symbols represent individual mice. Correlation
coefficient (r) was 0.86. (E) Aicda-cre/Rosa-tdRFP/Fucci mouse (64-week) spleen TCRb
+CD4
+ cells were sorted into CD44
hi RFP
+ and RFP
2 EM cells as
well as CD44
lo naı ¨ve cells. Cells were gated to the S/G2/M phase of the cell cycle. Results are representative of analyses of 4 animals. SPL, spleen; mLN,
mesenteric lymph node; PP, Peyer’s patch; R1, region 1; R2, region 2; R3, region 3.
doi:10.1371/journal.pone.0029141.g003
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PLoS ONE | www.plosone.org 8 December 2011 | Volume 6 | Issue 12 | e29141[49], which binds to bacterial components and activates NF-kB.
Our finding that AID was more prominently expressed in the
mMT background may reflect the increased environmental stimuli
under such an immunodeficient condition. That is, in the absence
of normal Ig production, the homeostasis of intestinal microbiota
could be severely disturbed; causing increased systemic stimulation
by aberrant bacterial components [50] and increasing the chance
of NF-kB activation in T cells.
The biological significance of AID expressed in T cells is
unclear. Although SHM on Tcr has been reported, we were not
able to detect it [51]; however, we cannot exclude the possibility
that a limited number of T-cell clones accumulated TCR
mutations. On the other hand, because the Aicda expression in T
cells is not abundant, we cannot exclude the possibility that the
expression simply results from a leaky transcriptional activation
and has no functional relevance. Another aspect of AID expression
is its involvement in tumorigenesis, since AID overexpression in
vivo efficiently generates T-cell tumors [14]. Although we could not
detect significant AID-induced Myc mutations in the exAID T
cells, it is possible that even rare AID expression can still increase
the probability of tumor formation. In this context, it is noteworthy
that human T cell leukemia virus 1 (HTLV-1) infection, which
causes T cell leukemia after a prolonged course, can induce Aicda
expression in infected T cells [52,53].
Immature B cells have been reported to express low levels of
AID, for which the Toll-like receptor signal is responsible [20].
SHM in immature B cells has been proposed to contribute
diversity to the primary repertoire [20–22,54]. It is not clear,
however, whether such mechanisms are critical for B-cell
repertoire maintenance. ExAID cells comprised only 5–10% of
immature B cells, and the average level of AID mRNA expression
was less than 10% of that in GC B cells. Aicda expression in
immature B cells may be induced or triggered in part of the
population, rather than intrinsically programmed. The AID
expressed in immature B cells has been suggested to play a role
in the negative selection of auto-reactive B cells [20,23,24]. ExAID
immature B cells might have expressed BCR reactive to
environmental antigens, including self-antigens, and such BCR
could be edited to change its specificity.
Recently, two groups reported analogous strategies for
analyzing AID expression in memory B cells [55,56]; these
reports did not study AID in immature B cells, as our study
did. Differences may be due at least partly to the cre expression
level or the reporter sensitivity. Dogan et al. used the cre-ER
system, in which cre is inactive until tamoxifen is administered
[ 5 6 ] .T h i ss y s t e mi se x c e l l e n tf o rl a b e l i n gt h ec e l l sa to n e
particular moment by tamoxifen injection, but it does not
allow the accumulation of labeled exAID cells. Despite these
Figure 4. T-B interaction is not required for Aicda expression in T cells. (A) Results of B220 and IgM staining of Aicda-cre/R26R/mMT and
Aicda-cre/R26R spleen (SPL) cells from 35-week-old animals are shown. (B) LacZ expressed in Aicda-cre/R26R/mMT (upper) and Aicda-cre/R26R (lower)
spleen T cells. Naive and EM CD4
+ T cells were gated as populations with CD3
+CD4
+CD62L
hiCD44
lo and CD3
+CD4
+CD62L
loCD44
hi phenotypes,
respectively. FACS data shown are representative of five independent experiments. (C) Endogenous Aicda mRNA expression in peripheral B and CD4
+
T cells was quantified by real-time PCR with TaqmanH probes. Pooled spleen and lymph node cells were sorted and analyzed. Each value was
normalized to the Ppib signal and shown as a number relative to the signal of germinal center B cells in each experiment; therefore, in this graph, one
corresponds to the signal equivalent to germinal center B cells. The error bar indicates the standard deviation of triplicate PCR. The results are
representative of two independent sorting experiments using two animals each. The following markers were used to define each fraction: germinal
center B, B220
+ CD38
2; transitional B, B220
+ IgM
hi IgD
lo CD21
lo; naive B, B220
+ IgD
hi IgM
lo; naive T, B220
2 CD3
+ CD4
+ CD62L
hi CD44
lo LacZ
2;E MT
(LacZ
2), B220
2 CD3
+ CD4
+ CD62L
lo CD44
hi LacZ
2; and EM T (LacZ
+), B220
2 CD3
+ CD4
+ CD62L
lo CD44
hi LacZ
+. (D) Human CD2 and LacZ expression in
the peripheral CD4
+ T-cell fraction in 33-week-old Aicda-cre/R26R/mMT mice. EM T cells (B220
2 CD3
+ CD4
+ CD62L
lo) in the spleen (SPL) or lymph node
(LN) were examined for each mouse with the indicated genotype. Percentage within the gate is indicated.
doi:10.1371/journal.pone.0029141.g004
Figure 5. The localization of exAID CD3
+ cells in Peyer’s patches. Left panel: an image of a Peyer’s patch, taken with a low power field,
stained with CD3 (green), AID (blue), and RFP (red). The section was cut at the position where the germinal center was dense. The dotted line
indicates part of a T-B border. Bar represents 200 mm. Right panels: enlarged view of the area indicated in the left panel. White arrows indicate CD3
+
RFP
+ double-positive cells.
doi:10.1371/journal.pone.0029141.g005
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PLoS ONE | www.plosone.org 10 December 2011 | Volume 6 | Issue 12 | e29141differences, all the systems clearly detected AID-expressing
B cells in the GC. ExAID B cells, which have been proposed
to be memory B cells [56], actually accumulated after 40 weeks
of age. However, the majority of exAID cells were non-switched
cells (IgM
+ IgD
+), even in very old animals. This may suggest
that switched memory B cells are not a major population.
Alternatively, such cells may emigrate from the spleen. The
importance of memory plasma cells in humoral memory has
recently been reinforced [57]. It is possible that switched cells
preferentially differentiate to plasma cells, as earlier proposed
[56].
Several groups have reported the presence of AID mRNA in
germ cells [25,26,58,59]. It has been proposed that AID plays a
critical role in reprogramming the DNA epigenetic mark.
However, it is difficult to reconcile this with the long-term
observation that AID knockout mice are fertile and physiolog-
ically normal. We only occasionally detected an RFP-positive
seminiferous tubule; therefore, the expression is unlikely to be a
developmentally programmed event that occurs in every cell. In
the ovary, consistent with previous reports, we observed many
RFP
+ granular and Theca cells in ovarian follicles, whereas the
oocytes appeared to be RFP
2. We cannot exclude the possibility
that our detection system is limited. Moreover, in contrast to
sperm, the number of oocytes that could be examined by our
procedure is limited. Although we do not exclude the possibility
that some of oocytes occasionally express the Aicda gene, it is clear
that AID expression in non-lymphoid tissues is either very low or
a rare event under normal conditions. Therefore, strong
pathogen stimulation is likely to be needed to trigger AID
expression in non-lymphoid cells, which could lead to tumori-
genesis.
Materials and Methods
Mice
Aicda-cre [27], R26R [29], Rosa-tdRFP [28], Fucci [33], mMT
[34] and CD3e
2/2 [60] mice were bred and maintained in
specific pathogen-free conditions at the Institute of Laboratory
Animals, Kyoto University, and in the animal facility at RIKEN.
These animals were backcrossed at least 7 times on a C57BL/6
background. All experimental protocols involving animal use were
approved by the Kyoto University Animal Research Committee
and/or the Institutional Animal Care and Use Committee at
RIKEN (Protocol number MedKyo10055).
Antibody staining, LacZ detection and cell sorting
Cells were suspended in FACS buffer (PBS supplemented with
4% FBS, 1 mM HEPES, and 0.6% sodium citrate). The following
antibodies were used for staining: monoclonal antibodies conju-
gated with FITC, PE, PE-Cy7, APC, APC-Cy7, Biotin or Pacific-
Figure 6. Distinct functional feature of exAID T cells. (A) Naive T (CD3
+ CD4
+ CD62L
hi CD44
lo) and EM T (CD3
+ CD4
+ CD62L
lo CD44
hi) cells, with
or without LacZ, from Aicda-cre/R26R spleens were gated and examined for the indicated molecules. (B) Cytokine production of naive (diamond) and
EM (LacZ
2, triangle; LacZ
+, square) T-cell fractions after stimulation with PMA and ionomycin is shown for the indicated time points. Unstimulated
LacZ
2 EM cells (non-stim., cross) were used as negative controls. Each symbol represents the result of an individual sample of multiple cultures (naive,
n=2; LacZ
+, n=6; LacZ
2, n=8; non-stim., n=4). (C) TGF-b production 48 hours after PMA ionomycin addition, measured by ELISA. Symbols are the
same as in (B). The result is representative of three independent experiments. IL, interleukin; IFN, interferon; TNF, tumor necrosis factor.
doi:10.1371/journal.pone.0029141.g006
Figure 7. Generation of exAID CD4
+ T cells in vivo by Adoptive transfer to CD3e
2/2 mice. (A) RFP expression of CD4
+ T cells recovered from
spleen, mesenteric lymph node, and small intestine of CD3e
2/2 mice transferred indicated phenotype of T cells. (B) CD4
+ T cells that were recovered
from the spleen, mesenteric lymph node, Peyer’s patch, small intestine and large intestine of the mice transferred RFP
2 EM (n=3; square) and RFP
+
EM CD4
+ T cells (n=3; triangle) as well as naı ¨ve T cells (n=2; square) were pooled; the total number of cells was counted and plotted. Average
numbers are shown by column graphs. (C) IFN-c and IL-10 double producing cell from EM CD4
+ T cells after the adoptive transfer. IFN-c and IL-10
expression in spleen CD4
+ T cells obtained from T-cell-transferred CD3e
2/2 mice were analyzed by intra-cellular cytokine staining. Recovered cells
were stimulated with PMA and ionomycin for 4 hours before the staining. SPL, spleen; mLN, mesenteric lymph node; Si, small intestine; memory,
effector memory.
doi:10.1371/journal.pone.0029141.g007
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IgM (R6-60.2), IgD (11-26), CD38 (90), CD3 (500A2), CD4
(GK1.5), CD8 (53-6.7), CD44 (IM7), CD62L (MEL-14), NKG2D
(CX5), Dx5, NK1.1 (PK136), CCR7 (4B12), PSGL-1 (2PH1),
ICOS (15F9), CXCR5 (2G8), CXCR4 (2B11), or hCD2 (RPA-
2.10) (BD Biosciences or eBioscience). FITC conjugated or
biotinylated PNA (VECTOR Laboratories) was also used.
Biotinylated reagents were detected with either streptavidin-
APC-Cy7 or streptavidin-APC (BD Biosciences). For LacZ
detection, equal volumes of cell suspension and 2 mM fluoresce-
in-di-b-galactopyranoside (FDG) in H2O were mixed at 37uC for
1 min. Stained cells were analyzed and sorted by FACS CantoII
(BD Biosciences) and FACSAria, respectively, and analyzed with
FlowJo software (TreeStar, Inc.). A live lymphocyte population
was gated according to forward-side scatters and 7-amino-
actinomycin D staining.
Cell culture and cytokine detection
Sorted cells were cultured with PMA (50 ng/ml) and
ionomycin (1 mg/ml) in RPMI-1640 supplemented with 10%
fetal calf serum, 2 mM L-gln, 100 mg/ml penicillin, 100 mg/ml
streptomycin, and 1 mM sodium pyruvate. In some experiments,
cells were stimulated by pre-coating plates with 2 mg/ml anti-
mouse CD3e (145-2C11, eBioscience) and 2 mg/ml anti-mouse
CD28 (37.51, eBioscience) with or without added cytokine
combinations, including TGF-b (3 ng/ml), IL-6 (20 ng/ml), IL-
12 (5 ng/ml; BD Pharmingen), or IL-4 (10 ng/ml; R&D
Systems). Concentrations of IL-2, IL-4, IL-10, IL-17, IFN-c,
and TNF-a in culture supernatants were measured by ELISA, a
Ready-SET-Go kit (eBioscience), a CBA Mouse Th1/Th2/Th17
cytokine kit (BD Bioscience), or a TGF-b1 Emax ImmunoAssay
System (Promega), used according to the manufacturer’s
protocol.
Quantitative Real-time PCR
Total RNA was extracted by TRIzol reagent (Invitrogen Life
Technologies), and cDNA was synthesized with TaqManH
Reverse Transcription Reagents (Applied Biosystems) or a Light-
Cycler RNA Pre-Amplification Kit (Roche). The Aicda, Igh-M,
Cd19, and Gapdh expressions were assessed with TaqManH
Gene Expression Assays (Applied Biosystems; Mm00507774_m1,
Mm01718956_m1, Mm00515428_m1, and Mm99999915_g1)
using Applied Biosystem’s 7900HT PCR system. Gene expression
was normalized to the Gapdh or Ppib expression as assessed by iQ
Sybr green supermix (Bio-Rad Laboratories, Inc.) with cyclophi-
lin-F and cyclophilin-R primers (Table S3).
Immunohistochemistry
Histological staining was done essentially as described elsewhere
[61]. Briefly, tissues were fixed in 4% paraformaldehyde at 4uC,
incubated in 30% sucrose at 4uC overnight, embedded in OCT
compound (Sakura Finetechnical), snap-frozen in liquid N2, and
then sectioned at a thickness of 8 mm with a Cryostat. The sections
were blocked in TNB buffer (PerkinElmer Life Science) containing
5% normal donkey serum, using the Streptavidin/Biotin Blocking
Kit (Vector Laboratories). Endogenous peroxidase activity was
quenched with 1% H2O2. The primary antibodies were applied in
TNB buffer for 1.5 h at room temperature, or overnight at 4uC.
Slides were washed and incubated with biotin-conjugated
secondary antibodies, and then incubated with streptavidin–
HRP conjugate (Zymed Laboratories). Antigens were detected
using tyramide-FITC or tyramidetetramethylrhodamine from the
tyramide signal amplification kit (PerkinElmer Life Science)
according to the manufacturer’s instructions. Stained slides were
mounted with Fluoromount-G (Southern Biotechnology Associ-
ates). To observe RFP without immunostaining, slides were
prepared as above, and then mounted with Slow fade Gold with
DAPI (Invitrogen). Antibody used for AID staining was MAID-2
[62].
Sequencing for Ig, Myc and TCRs
The IgV downstream region was amplified and sequenced as
described [4]. The 1-kb region of Myc exon1-intron1 was
amplified by PCR from the genomic DNA of naı ¨ve, LacZ
+ EM,
and LacZ
2 EM T cells with the high fidelity polymerase Pyrobest
(TaKaRa), using Myc-F and Myc-R primers for 35 cycles. PCR
products were first A-tailed by Taq, and then cloned by the T-
vector pMD20 (TaKaRa) for sequencing. In some experiments,
mice were immunized once with 100 mg of trinitrophenyl (TNP)-
ova in complete Freund’s adjuvant, and boosted 4 times per 2-
week interval with 50 mg TNP-ova in incomplete Freund’s
adjuvant.
RNA from sorted T cells was reverse-transcribed with a mixture
of specific primers for TCR Ca and Cb (Ca-1 and Cb-1).
Synthesized single-stranded cDNA was purified with the Affyme-
trix cDNA clean-up module (Affymetrix). Single-stranded DNA
was tailed by terminal deoxynucleotide transferase (New England
Biolabs) with 190 mM dGTP for 10 minutes at 37uC, purified with
Table 2. Mutation frequency of Myc exon 1-intron 1 region.
Exp. Cell Mutation rate(/base pair) Mutated base/Total base
Non imm. Naı ¨ve T 0.20610
24 3/153,114
EM T Rosa
+ 0.40610
24 7/174,408
EM T Rosa
2 0.56610
24 2/35,490
Immunized*
Exp. 1 Naı ¨ve T 0.16610
24 3/182,520
EM T Rosa
+ 0.52610
24 8/153,114
EM T Rosa
2 0.34610
24 4/118,235
Exp. 2 Naı ¨ve T ,0.14610
24 0/73,340
EM T Rosa
+ 0.26610
24 3/114,835
EM T Rosa
2 0.35610
24 5/143,785
*Mice immunized TNP-ova emulsified with incomplete Freund’s adjuvant. EM, effector memory; Exp, experiment; Rosa, LacZ or RFP.
doi:10.1371/journal.pone.0029141.t002
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with a mixture of primers (Ca-2-Xho, 0.3 mM; Cb-2-Xho,
0.3 mM; anchor-Xba, 0.3 mM; anchor+dC-Xba, 0.05 mM) by
Prime STAR HS (TaKaRa) for 35 cycles. PCR products around
400–800 bp in size were purified by agarose gel electrophoresis,
then randomly cloned into a pBluescript vector at XbaI and XhoI
sites for sequencing. Sequence data was searched on IMGT/
GENE-DB [63] and on NCBI blast.
Adoptive transfer
Spleen and lymph node cells of Aicda-cre/Rosa-tdRFP mice
were pooled and used for the sorting. One hundred thousand of
CD62L
hiCD44
loRFP
2 naı ¨ve T cells, 1610
5 CD62L
loCD44-
hiRFP
2 and 1610
5 CD62L
loCD44
hiRFP
+ EM T cells were
injected intravenously into CD3e
2/2 mice. They were analyzed at
10 weeks after the transfer.
Statistics
P values (two-tailed) were calculated by Fisher’s exact test.
Correlation coefficient between age and percentage of exAID
lymphocytes were calculated by Excel software (Microsoft)
Supporting Information
Figure S1 Characterization of Aicda-cre mouse crossed
with Rosa reporter mice. (A) Schematic representation of
Aicda-cre, R26R and Rosa-tdRFP alleles. (B) FACS analysis of
B220
+ cells for hCD2 and RFP expression in peripheral lymphoid
tissues of Aicda-cre/Rosa-tdRFP mice (31-week) are shown. CD95
(Fas) is an activated B cell marker. (C) Estimated absolute numbers
of Rosa marker (R26R, diamond; Rosa-tdRFP, cross) positive
hCD2
2 B220
+ exAID B cells were plotted by age. (D) Ig isotype of
LacZ
2 and LacZ
+ B cells in the spleen of aged mouse (64-week).
The result is representative for three independent staining
experiments. SPL, spleen; LN, lymph node; PP, Peyer’s patch.
(TIFF)
Figure S2 ExAID CD4
+ T cells visualized by Rosa-tdRFP
system. (A) (B) Spleen cells from Aicda-cre/Rosa-tdRFP mouse
(33-week, upper panels) were stained with indicated markers. RFP
positive CD4
+ T cells appeared Aicda-cre dependent manner. (B)
RFP histograms of the CD3
+CD4
+ fraction were shown. (C)
Spleen (SPL), lymph node (LN) and Peyer’s patch (PP) T cells were
immuno-stained and gated as indicated.
(TIFF)
Figure S3 Analysis of non-B exAID cells. (A) NK cells
contain a small fraction of cells with Aicda expression history.
Spleen cells from Aicda-cre/R26R mouse (21-week) were stained
by NK cell markers. Almost no NK marker positive cells are
detected within CD3
+ CD4
+ T cells while CD3
2 CD4
2 contains
few but obvious LacZ
+ NK marker positive cells. The number
indicates percent of the fraction in each quadrant among gated
cells. The result was representative for three independent
experiments with 1 or 2 mice. (B) Estimated absolute numbers
of Rosa marker (R26R, diamond; Rosa-tdRFP, cross) positive
CD4
+ B220
2 exAID T cells were plotted by age. (C) Percentage of
Rosa marker positive cells (R26R, diamond; Rosa-tdRFP, cross) in
cytotoxic T cells fraction in the spleen. The fractions were defined
as CD8
+ (filled diamond) or CD4
2 (open diamond) T cells. The x-
axis is the age of mouse (week). (D) PD-1 expression of naı ¨ve
(CD62L
hi), non-exAID effector memory (CD62L
lo LacZ
2) and
exAID effector memory (CD62L
lo LacZ
+) helper T cells (CD3
+
CD4
+) in aged (65-week) mouse. The result was representative for
the analysis of three old mice (65- or 64-week).
(TIFF)
Figure S4 In vitro stimulation of CD4
+ T cells. (A) CD4 T
cells were fractionated to Naı ¨ve, and LacZ
+ and LacZ
2 effector
memory T cells by sorting according to their expression of CD44
and CD62L. They were cultured with 2 mg/ml anti-mouse CD3e
(clone 145-2C11, eBioscience) and 2 ug/ml anti-mouse CD28
(clone 37.51, eBioscience) for 2 Days. IL-2, IL-4, IL-17, IFN-c and
TNF-a in culture supernatants were measured by ELISA, Ready-
SET-Go kit (eBioscience). The experiment was done twice and the
results were essentially the same. (B) In vitro stimulation of Naive
CD4
+ cells failed to induce AID expression. Naive CD4
+ T cells
were sorted from Aicda-cre/R26R mice and cultured in vitro with
various combination of stimulants with which T cells should
polarize to different types of helper T cell states as indicated above
each panel. The left most is the culture with un-fractionated CD4
T cells that included LacZ
+ cells as a control culture. The data is
the representative of two independent experiments.
(TIF)
Figure S5 Histological analyses of testis and ovary.
Frozen section of fixed tissues from Aicda-cre/Rosa-tdRFP and
control mice (wt) were examined. Nuclear counter staining of
DAPI and bright field image (BF) were shown below and above.
(A) Images of testis. Boxed regions were magnified as indicated by
arrows. A scale bar is shown in the high power magnification
picture of the DAPI staining. Scale bar=25 mm. (B) Images of
ovary. Three different follicles of Aicda-cre/Rosa-tdRFP ovary are
shown. Two sets of males and one set of female with the same
number of controls were examined.
(TIF)
Table S1 Mutation frequency of Myc exon 1-intron 1
region.
(PDF)
Table S2 Mutation analysis on randomly cloned TCR
cDNA.
(PDF)
Table S3 Primers used in this study.
(PDF)
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